Neumora Share Price

Neumora Share Price

NASDAQ: NMRA | Micro Cap | Healthcare
$0.35
-$0.01 (-2.85%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Neumora Stock Performance

Open
$0.36
Prev. Close
$0.36
Circuit Range
N/A
Day Range
$0.35 - $0.37
Year Range
$0.30 - $3.65
Volume
28,762
Average Traded
$0.35

Neumora Share Price Today

As of 20 November 2026, Neumora Therapeutics, Inc.'s share price is $0.35. The stock opened at $0.36, compared to its previous close of $0.36. During today's trading session, Neumora Therapeutics, Inc.'s share price traded between $0.35 and $0.37, with an average price of $0.36. Over the past 52 weeks, the stock has recorded a high of $3.65 and a low of $0.30. In terms of performance, Neumora Therapeutics, Inc.'s share price has declined by 81.03% over the last six months and is down 84.33% on a year-on-year basis.

Neumora Share Price Chart

Line chart of the Neumora price trend over the selected period. The price fell overall, ranging from 0.34 to 0.37, ending at 0.36.
$0.35$0.37
L
Show Current Price
H

Neumora Stock Fundamentals & Key Indicators

Market Cap
$57.35M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.13
Revenue (TTM)
$0.00
Return On Equity (TTM)
-477.87%
Profit Margin
N/A
Debt to Equity
1.19
Quarterly Earnings Growth YoY
42.07%

Neumora Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$59.45-$53.46-$43.08-$34.44
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A10.08%19.42%20.06%

Neumora Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$235.93-$243.79-$236.93
Net Profit MarginN/AN/AN/A
Income ChangeN/A-3.33%2.81%

Neumora Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets0.512.9217.92
Current Assets190.54314.06478.28
Total Assets191.05316.97496.2
Non Current Liabilities54.730.022.01
Current Liabilities32.4529.8925.11
Total Liabilities87.1829.9127.12
Shareholders' Equity103.87287.06469.08

Neumora Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-206.44-182.94-167.87
Investing168.52-70.5668.98
Financing77.0921.6231.94

About Neumora

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Neumora Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.38
$0.35
-5.46%
Oct 2026
$0.61
$0.37
-39.80%
Sep 2026
$1.33
$0.61
-58.92%
Aug 2026
$1.62
$1.48
-8.07%
Jul 2026
$1.69
$1.61
-4.73%
Jun 2026
$1.85
$1.69
-8.65%
May 2026
$2.46
$1.85
-24.80%
Apr 2026
$1.99
$2.46
+26.48%
Mar 2026
$2.85
$1.95
-44.11%
Feb 2026
$2.05
$3.48
+74.87%
Jan 2026
$1.79
$1.99
+11.48%
Dec 2025
$2.50
$1.78
-20.31%

Neumora Share Price FAQs